You are here

Scheduling delegates' interim decisions and invitation for further comment: ACCS/ACMS, November 2017

Scheduling medicines and poisons

5 February 2018

Book pagination

Part A - Interim decisions on matters referred to an expert advisory committee (November 2017)

Advisory Committee on Medicines Scheduling (ACMS #22)

Summary of delegate's final decisions
Substance Interim Decision
Hyaluronic acid

Schedule 4 - Amend Entry

HYALURONIC ACID AND ITS POLYMERS in preparations for injection or implantation.

The proposed implementation date is 1 June 2018.

Cardarine

Schedule 10 - New Entry

CARDARINE.

Index – New Entry

CARDARINE
Schedule 10

The proposed implementation date is 1 June 2018.

Stenabolic (SR9009)

Schedule 4 - New Entry

# STENABOLIC (SR9009) and other synthetic REV-ERB agonists.

Appendix D, Part 5 - New Entry

STENABOLIC (SR9009) and other synthetic REV-ERB agonists.

Index – New Entry

STENABOLIC (SR9009) and other synthetic REV-ERB agonists
cross reference: SR9011, GSK2945, GSK0999, GSK5072, GSK2667

Schedule 4
Appendix D, Part 5

The proposed implementation date is 1 June 2018.

Ibutamoren

Schedule 4 - New Entry

# IBUTAMOREN.

Appendix D, Part 5 – New Entry

IBUTAMOREN.

Index – New Entry

IBUTAMOREN
cross reference: MK-677, NUTROBAL

Schedule 4
Appendix D, Part 5

The proposed implementation date is 1 June 2018.

alpha-Pyrrolidinovalerophenone (alpha-PVP) and related substances methylone and synthetic cathinones

Schedule 9 - New Entry

ALPHA-PYRROLIDINOVALEROPHENONE *(ALPHA-PVP).

Schedule 9 - New Entry

METHYLONE *(MDMC).

Schedule 9 - Amend Entry

CATHINONES except when separately specified in these Schedules.

Index - Amend Entry

CATHINONES
cross reference: SYNTHETIC CATHINONES

The proposed implementation date is 1 June 2018.

Ibuprofen

The delegate’s interim decision is that the current scheduling of ibuprofen remains appropriate

Melanotan II

Schedule 4 - New Entry

MELANOTAN II.

Index - New Entry

MELANOTAN II
cross reference: α–MELANOCYTE STIMULATING HORMONE

Schedule 4

The proposed implementation date is 1 June 2018.

Orphenadrine

The delegate’s interim decision is that the current scheduling of ibuprofen remains appropriate.

Clotrimazole

The delegate’s interim decision is that the current scheduling of ibuprofen remains appropriate.

Book pagination